Spero Therapeutics, Inc.·4

Aug 18, 5:07 PM ET

Pottage John C Jr 4

4 · Spero Therapeutics, Inc. · Filed Aug 18, 2021

Insider Transaction Report

Form 4
Period: 2021-08-17
Transactions
  • Award

    Stock Option (right to buy)

    2021-08-17+7,5007,500 total
    Exercise: $13.69Exp: 2031-08-17Common Stock (7,500 underlying)
Footnotes (1)
  • [F1]The shares underlying this option will vest and become exercisable in full on August 17, 2022 subject to the Reporting Person's continued service as a director through the vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION